 eluded the authors in several areas. We could
not completely agree on the role of carotid stenting in asymptomatic patients. We did agree that data supporting stenting in
this setting were of poor quality because of the absence of a
medically managed control group. A majority felt that patients
with acceptable medical risk, high anatomic risk, and compelling carotid pathology should be considered candidates for
stenting. A minority felt that in the absence of trials comparing
medical